Emerging Endotypes of Chronic Rhinosinusitis and Its Application to Precision Medicine

Overview

Journal Allergy Asthma Immunol Res

Date 2017 May 13

PMID 28497916

Citations 42

Authors

Dae Woo Kim

Seong H Cho

Affiliations

Soon will be listed here.

Abstract

Chronic rhinosinusitis (CRS) is a heterogeneous inflammatory disease with various underlying pathophysiologic mechanisms which translate to endotypes, in contrast to clinical phenotypes or histological subtypes. Defining endotypes can help clinicians predict disease prognosis, select subjects suitable for a specific therapy, and assess risks for comorbid conditions, including asthma. Therefore, with recent advancement of biologicals in CRS clinical trials, endotyping can be a breakthrough in treating recalcitrant CRS. CRS is caused by dysregulated immunologic responses to external stimuli, which induce various inflammatory mediators from inflammatory cells, including innate lymphoid cells (ILCs) and T lymphocytes as well as epithelial cells. Thymic stromal lymphopoietin (TSLP), interleukin (IL)-25, and IL-33, which are mainly secreted by epithelial cells in response to external stimuli, act on type 2 ILCs and T helper 2 (Th2) cells, inducing IL-4, IL-5, and IL-13. Local immunoglobulin E (IgE) production is also a signature event in nasal polyps (NP). These inflammatory mediators are novel potential therapeutic targets for recalcitrant CRS. This article reviews recent publications regarding endotypes and endotype-based therapeutic strategies in CRS and NP.

Citing Articles

Chronic rhinosinusitis with nasal polyps: Key considerations in the multidisciplinary team approach.

Pfaar O, Peters A, Taille C, Teeling T, Silver J, Chan R Clin Transl Allergy. 2025; 15(1):e70010.

PMID: 39794887 PMC: 11723824. DOI: 10.1002/clt2.70010.

The cyclooxygenase-2 upregulation mediates production of PGE2 autacoid to positively regulate interleukin-6 secretion in chronic rhinosinusitis with nasal polyps and polyp-derived fibroblasts.

Shieh J, Tsai Y, Ma M, Chen C, Wu W Sci Rep. 2024; 14(1):7559.

PMID: 38555391 PMC: 10981736. DOI: 10.1038/s41598-024-58143-2.

The interplay of inflammation and remodeling in the pathogenesis of chronic rhinosinusitis: current understanding and future directions.

Gong X, Han Z, Fan H, Wu Y, He Y, Fu Y Front Immunol. 2023; 14:1238673.

PMID: 37771597 PMC: 10523020. DOI: 10.3389/fimmu.2023.1238673.

Systematic Review of Protein Biomarkers in Adult Patients With Chronic Rhinosinusitis.

Gokani S, Espehana A, Pratas A, Luke L, Sharma E, Mattock J Am J Rhinol Allergy. 2023; 37(6):705-729.

PMID: 37491901 PMC: 10548774. DOI: 10.1177/19458924231190568.

Sense of smell in chronic rhinosinusitis: A multicentric study on 811 patients.

Macchi A, Giorli A, Cantone E, Pipolo G, Arnone F, Barbone U Front Allergy. 2023; 4:1083964.

PMID: 37152304 PMC: 10160403. DOI: 10.3389/falgy.2023.1083964.

References

Cho S, Kim D, Gevaert P . Chronic Rhinosinusitis without Nasal Polyps. J Allergy Clin Immunol Pract. 2016; 4(4):575-82. PMC: 4939221. DOI: 10.1016/j.jaip.2016.04.015. View

Li X, Meng J, Qiao X, Liu Y, Liu F, Zhang N . Expression of TGF, matrix metalloproteinases, and tissue inhibitors in Chinese chronic rhinosinusitis. J Allergy Clin Immunol. 2010; 125(5):1061-8. DOI: 10.1016/j.jaci.2010.02.023. View

Gauvreau G, OByrne P, Boulet L, Wang Y, Cockcroft D, Bigler J . Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N Engl J Med. 2014; 370(22):2102-10. DOI: 10.1056/NEJMoa1402895. View

Fokkens W, Lund V, Mullol J, Bachert C, Alobid I, Baroody F . European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl. 2012; 23. View

Kim H, Chang Y, Subramanian S, Lee H, Albacker L, Matangkasombut P . Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J Allergy Clin Immunol. 2011; 129(1):216-27.e1-6. PMC: 3246069. DOI: 10.1016/j.jaci.2011.10.036. View

Kato A, Favoreto Jr S, Avila P, Schleimer R . TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells. J Immunol. 2007; 179(2):1080-7. PMC: 2220044. DOI: 10.4049/jimmunol.179.2.1080. View

Baba S, Kondo K, Kanaya K, Suzukawa K, Ushio M, Urata S . Expression of IL-33 and its receptor ST2 in chronic rhinosinusitis with nasal polyps. Laryngoscope. 2013; 124(4):E115-22. DOI: 10.1002/lary.24462. View

Fokkens W, Lund V, Mullol J, Bachert C, Alobid I, Baroody F . EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012; 50(1):1-12. DOI: 10.4193/Rhino12.000. View

Gordon E, Simpson L, Rios C, Ringel L, Lachowicz-Scroggins M, Peters M . Alternative splicing of interleukin-33 and type 2 inflammation in asthma. Proc Natl Acad Sci U S A. 2016; 113(31):8765-70. PMC: 4978244. DOI: 10.1073/pnas.1601914113. View

10.

Cavone L, Cuppari C, Manti S, Grasso L, Arrigo T, Calamai L . Increase in the Level of Proinflammatory Cytokine HMGB1 in Nasal Fluids of Patients With Rhinitis and its Sequestration by Glycyrrhizin Induces Eosinophil Cell Death. Clin Exp Otorhinolaryngol. 2015; 8(2):123-8. PMC: 4451536. DOI: 10.3342/ceo.2015.8.2.123. View

11.

Ho J, Bailey M, Zaunders J, Mrad N, Sacks R, Sewell W . Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia. Clin Exp Allergy. 2014; 45(2):394-403. DOI: 10.1111/cea.12462. View

12.

Shaw J, Fakhri S, Citardi M, Porter P, Corry D, Kheradmand F . IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps. Am J Respir Crit Care Med. 2013; 188(4):432-9. PMC: 5448506. DOI: 10.1164/rccm.201212-2227OC. View

13.

Lan F, Yuan B, Liu T, Luo X, Huang P, Liu Y . Interleukin-33 facilitates neutrophil recruitment and bacterial clearance in S. aureus-caused peritonitis. Mol Immunol. 2016; 72:74-80. DOI: 10.1016/j.molimm.2016.03.004. View

14.

Lam E, Kariyawasam H, Rana B, Durham S, McKenzie A, Powell N . IL-25/IL-33-responsive TH2 cells characterize nasal polyps with a default TH17 signature in nasal mucosa. J Allergy Clin Immunol. 2015; 137(5):1514-24. PMC: 4852988. DOI: 10.1016/j.jaci.2015.10.019. View

15.

Van Bruaene N, C P, Van Crombruggen K, De Ruyck N, Holtappels G, Van Cauwenberge P . Inflammation and remodelling patterns in early stage chronic rhinosinusitis. Clin Exp Allergy. 2011; 42(6):883-90. DOI: 10.1111/j.1365-2222.2011.03898.x. View

16.

Sugimoto T, Ishikawa Y, Yoshimoto T, Hayashi N, Fujimoto J, Nakanishi K . Interleukin 18 acts on memory T helper cells type 1 to induce airway inflammation and hyperresponsiveness in a naive host mouse. J Exp Med. 2004; 199(4):535-45. PMC: 2211833. DOI: 10.1084/jem.20031368. View

17.

Zhang N, Gevaert P, Van Zele T, Perez-Novo C, Patou J, Holtappels G . An update on the impact of Staphylococcus aureus enterotoxins in chronic sinusitis with nasal polyposis. Rhinology. 2005; 43(3):162-8. View

18.

Kim D, Kim D, Jo A, Jin H, Eun K, Mo J . Age-Related Decline of Neutrophilic Inflammation Is Associated with Better Postoperative Prognosis in Non-eosinophilic Nasal Polyps. PLoS One. 2016; 11(2):e0148442. PMC: 4743847. DOI: 10.1371/journal.pone.0148442. View

19.

Wang X, Zhang N, Bo M, Holtappels G, Zheng M, Lou H . Diversity of T cytokine profiles in patients with chronic rhinosinusitis: A multicenter study in Europe, Asia, and Oceania. J Allergy Clin Immunol. 2016; 138(5):1344-1353. DOI: 10.1016/j.jaci.2016.05.041. View

20.

Kim D, Eun K, Jin H, Cho S, Kim D . Prolonged allergen exposure is associated with increased thymic stromal lymphopoietin expression and Th2-skewing in mouse models of chronic rhinosinusitis. Laryngoscope. 2016; 126(8):E265-72. DOI: 10.1002/lary.26004. View